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Abstract
Resulting from the combination of Raman spectroscopy and optical microscopy, Raman hyperspectral imaging 
has proven to be an indispensable tool in the pharmaceutical field. This article will broach a number of Raman 
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Introduction
In the pharmaceutical environment, and especially in the 
research and development field, the quality of the medicine 
is a critical step as it is facing challenges with increased 
demand from the regulatory affairs to improve the quality of 
a pharmaceutical drug product. In order to ensure its proper 
effect on the patient health, a product has to be manufactured 
with the appropriate quality. [1-3]
Today, a lot of techniques are used in pharmaceutical 
laboratories to ensure the quality of a drug product. Several 
tests such as dissolution profiles, stability studies or control of 
active content are required from the pharmaceutical guidelines 
and authorities to ensure that the analysed product is included 
within pre-determined specifications. In the QC labs, most of 
the analytical tools are based on chemical analyses (liquid 
chromatography, dissolution apparatus…) which generally 
damage the sample, require solvent and a lot of time or 
important human resources.  
In the last decade, the use of vibrational spectroscopy has 
grown quickly and has appeared as an alternative analytical 
tool to usual techniques [4-5]. By allowing fast and non-
destructive analysis, without needing sample preparations in 
most cases, these analytical tools are particularly appreciated 
by the analysts.
Since its discovery in 1928 by Raman and Krishnan [6], Raman 
spectroscopy, which is based on the inelastic scattering of 
light, has attracted increasing attention due to its numerous 
advantages, such as the lack of need to use organic solvents, 
the reduced sample preparation step and the ability to perform 
qualitative as well as quantitative analyses in relatively short 
data acquisition times [7]. 
Recently, Raman spectroscopy has been combined with 
optical microscopy, giving rise to Raman hyperspectral imaging 
[8]. The use of the latter has expanded in the pharmaceutical 
and biomedical fields since microspectroscopic techniques 
present several advantages by combining the acquisition 
of spatial and spectral information from a sample. Raman 
hyperspectral imaging allows to characterize the sample 
in terms of chemical (API and excipients identification and 
content for example) and physical properties (solid state, 
particle size, amongst others) by adding information on the 
spatial distribution. Therefore, data are collected in the form of 
a three-dimensional hyperspectral datacube (x,y and l) with x 
and y as spatial dimensions and l as spectral dimension.
Hyperspectral data analysis is based on chemometrics and 
may be divided in three main parts: (i) preprocessing of the 
raw spectral data, aiming at correcting the perturbations 
that occurred during the analysis or at limiting the effect of 
undesired phenomena to ease the access to the relevant 
information, (ii) processing of preprocessed data based on 
univariate (peak height, area or ratio) or multivariate data 
analysis (for instance PCA, ICA, MCR-ALS or PLS) depending 
on the data complexity and (iii) post-processing of the image. 
Each chemometric tool has its own specificities and will be 
used depending on the available and desired results [9]. 
However, more and more user-friendly software are provided 
directly by the manufacturer to help the analyst to manage 
conventional sample analysis.
In order to illustrate the power and the suitability of Raman 
chemical imaging, several pharmaceutical applications 
developed in our laboratory will be presented in this article.
Material and methods
For the collection of the hyperspectral datacube, a LabRAM 
HR Evolution (HORIBA Scientific) equipped with a two-
dimensional EMCCD (1600 x 200 pixels sensor) detector 
was used. A 785 nm laser (XTRA II single-frequency diode 
laser, Toptica Photonics AG), a 50x Fluotar long working 
distance objective (NA=0.55) and a 300 gr/mm grating were 
selected. The data were collected with the LabSpec 6 
software (HORIBA Scientific) and analyzed by using MATLAB 
homemade functions and PLS/MIA toolbox (Eigenvector).
Before analyzing the samples, their surfaces were prepared 
with a Leica EM Rapid milling system (Leica Microsystems) 
equipped with a tungsten carbide miller to obtain a plane and 
smooth surface.
Results and discussion
Identification and spatial distribution 
During pharmaceutical development or quality control, analysts 
must ensure the distribution of active(s) and excipients in the 
tablet. Indeed, the distribution of compounds is directly linked 
to the product stability (i.e. modification of crystalline form 
or degradation), active content (especially required for score 
tablet) and drug release (agglomerates can modify the profile). 
The Raman images make possible the characterisation of the 
pure compound in a pharmaceutical drug product and can 
provide its spatial distribution on the surface of a sample.
In this example, an effervescent tablet for fever and pain relief 
was analyzed by Raman imaging. First, a map of 4 x 4 mm² 
with a step size of 20 µm (low lateral resolution) was realized 
(Figure 1b). Once obtained, the datacube underwent pre-
processing (baseline correction) and processing (Multivariate 
Curve Resolution – Alternating Least Squares analysis (MCR-
ALS)) to resolve the different component spectra and spatial 
distribution [10]. After data treatment, the map allowed us to 
identify each component of the tablet (API and excipients alike) 
and to obtain information on both particle size and spatial 
distribution of each compound. 
Based on this information, one may be able to detect 
counterfeit tablets even if the correct API is present in the 
correct amount but if one excipient is different in nature or 
amount [11]. It is also possible to explain inconsistencies in 
dissolution profiles due to inhomogeneity in spatial distribution 
of API or to select the most homogeneous formulation without 
destructive analysis [12]. 
Another very important information that may be obtained is the 
particle size. In this case, the lateral resolution may be a critical 
parameter. This resolution can be enhanced by a decrease 
in the step size. The step size is the distance between two 
adjacent pixels. The bigger the step size, the lower the spatial 
(or lateral) resolution. However, at constant analyzed area, the 
lower the step size is, the higher the pixel (and therefore the 
spectra) number will be. If the number of pixels’ increases, the 
analysis time also does. The analyst must keep this in mind 
and design the analysis in function of the desired information. 
Figure 1b to figure 1d show three Raman hyperspectral images 
with the same number of pixels (200 x 200) and consequently 
the same analysis time. However, as the step size decreases 
the details increase but the obtained information is completely 
different. The blue particle highly resolved in Figure 1d (very 
accurate particle size with an effective lateral resolution 
of ~1 µm) is hardly observable in Figure 1b. But the spatial 
distribution and chemical composition of the tablet can only 
be observed in Figure 1b.
Particle size is not a crucial issue for tablets since this 
parameter may be obtained accurately on the raw materials. 
However, hyperspectral imaging is nearly the only technique 
that can provide this information on semi-solid formulations 
due to the melt step of the raw materials and recrystallization 
when the formulation is cooled [13].
Figure 1: Visible image of a tablet (a), distribution maps indicating the composition and the spatial distribution of six components (sodium bicarbonate, 
citric acid, acetylsalicylic acid, sorbitol, ascorbic acid and paracetamol) for a map size equal to 4 x 4 mm2 with a step size of 20 µm (b), 500 x 500 µm2 
with a step size of 2.5 µm (c) and 100 x 100 µm2 with a step size of 0.5 µm (d).
Solid state investigation
Solid state information is becoming more and more important 
in the pharmaceutical industry partly because of patent issues 
and partly because of the physical properties of the different 
polymorphs. Indeed, the pharmaceutical industry uses a lot of 
API coming from a total chemical synthesis, which are often 
BCS class II APIs [8]. It is therefore interesting to obtain specific 
polymorphs or the amorphous form of the API to enhance its 
aqueous solubility and increase its bioavailability. As the solid 
state is crucial for some formulations, it is crucial to be able 
to monitor it properly, during drug discovery, pharmaceutical 
development or stability studies.
Since Raman spectroscopy is one of the European 
Pharmacopoeia’s recommended technique (EP 9.1 general 
text 5.09) to characterize solid states of raw materials, it is 
consequently the same for hyperspectral Raman imaging. 
In this example, a tablet composed of the three polymorphs of 
mannitol (produced in house from the commercial β form) was 
analyzed by Raman hyperspectral imaging. Once obtained, 
the spectra were baseline corrected and processed by MCR-
ALS. This analysis allowed us to resolve both the spectra and 
distribution maps of each polymorph (Figure 2). It is therefore 
possible to use hyperspectral imaging as a tool to detect 
solid state transitions on samples placed in stability studies, 
especially because of its non-destructive character.
Even if it is often possible to characterize solid states based on 
the usual spectral range (200-1800 cm-1), it is recommended 
to work in the low-frequency Raman scattering (0-400 cm-1) 
as this range is the most affected by differences in crystalline 
lattices [14]. It is now possible to reach very low frequencies 
(up to 5 cm-1) on conventional Raman microspectrometry 
systems when using Volume Bragg Gratings (VBG) as laser 
rejection filters [15].
Surface-enhanced Raman scattering
The main issues limiting the implementation of Raman imaging 
in the pharmaceutical field are its low sensitivity and the 
appearance of autofluorescence especially with formulations 
comprising colored constituents or colored coatings. However, 
by combining Raman imaging with surface-enhanced Raman 
scattering (SERS), it is possible to fix these issues and to 
increase the number of pharmaceutical applications. 
In this context, one case which was studied in our 
laboratory was the quantitative detection of an impurity in a 
pharmaceutical formulation [16]. Impurities are, most of the 
time, present in a very low dosage in the pharmaceutical 
products, consequently preventing their detection using 
Raman imaging. Surface-enhanced Raman chemical imaging 
(SER-CI) was therefore used for the quantitative detection of an 
impurity. A rather simple pharmaceutical formulation based on 
paracetamol tablets, comprising a small number of excipients, 
was selected as a model. The aim of this study was to detect 
quantitatively 4-aminophenol (4-AP), the main impurity of 
paracetamol, using SER-CI. 4-AP is actively researched due 
to its hepatotoxicity and nephrotoxicity.
Figure 2: Raman spectrum of α, β, δ mannitol (a), distribution maps indicating the spatial distribution of mannitol forms (b) and α, β, δ distribution map 
indicating the composition and the spatial distribution of mannitol forms of a tablet (c).
During the development of this method, the SERS substrate 
synthesis was firstly considered. Silver nanoparticles (AgNps) 
were synthesized according to the protocol described by Lee 
and Meisel [17]. After their characterization in terms of size 
and shape, the surface of these AgNps was modified using 
1-butanethiol in order to follow the nanoparticles distribution 
along the paracetamol tablet surface. Then, different strategies 
to cover the tablet surface with the colloidal suspension 
of functionalized AgNps were tested and are described in 
Figure 3. In a first time, the tablet surface was covered by 
dropping AgNps on the top of these tablets as it is illustrated 
in Figure 3a. In a second time, the tablet surface was covered 
by dropping the AgNps on a microscope glass slide and by 
putting the tablets on the drop as it is illustrated in Figure 3b. 
The AgNps were absorbed by capillarity on the top of the 
tablets. A homogeneity study of the AgNps covering was 
further performed in order to select the best way to cover the 
tablet surface. Linescanning acquisitions were done along 
the tablet surface using Raman spectroscopy and it was 
observed that the method using the capillarity absorption was 
more appropriate.
Then, paracetamol tablets comprising different 
concentrations of 4-AP were prepared. These tablets were 
covered by AgNps using the capillary method before being 
analyzed using Raman imaging. The data acquired were 
processed using two different normalization approaches and 
the normalization by the band intensity of 1-butanethiol was 
shown to be the best one, reducing the inter-series variation. 
Finally, as it is illustrated in Figure 4, a SER-CI quantitative 
method was developed allowing the 4-AP detection from 
0.025% to 0.2% in paracetamol tablets. 
These researches will pave to way to new developments 
using Raman imaging applied to low dosage drugs or 
impurities in the pharmaceutical field.
Conclusion
As a conclusion, Raman microscopy can be considered as 
a powerful analytical tool in the pharmaceutical environment 
through the entire drug product life cycle. Indeed, it retains 
the advantages of Raman spectroscopy, namely compound 
identification, solid state characterization, but also add 
those of imaging, such as spatial distribution of compounds, 
particle size analysis or homogeneity of distribution analysis. 
Moreover, the application of hyperspectral imaging to SERS 
allows the analysis of low dosage drugs or impurities, which 
extends the field of application of the technique.
Figure 3: Strategies tested to cover the surface of a tablet with a suspension of nanoparticles: dropping nanoparticles on the tablet (a) or placing of a 
drop of nanoparticles on a glass slide and putting the tablet on it in order to let the drop be absorbed by the tablet by capillarity (b).
Figure 4: Concentration maps of 4-AP in a paracetamol tablet from 0.025% to 0.2% obtained by SERS chemical imaging [11].
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